Results 31 to 40 of about 600,025 (282)

Hippo/YAP signaling pathway: a new therapeutic target for diabetes mellitus and vascular complications. [PDF]

open access: yesTher Adv Endocrinol Metab, 2023
Diabetic angiopathy, which includes diabetic kidney disease (DKD), cardio-cerebrovascular disease, and diabetic retinopathy (DR) among other diseases, is one of the most common complications affecting diabetic patients. Among these, DKD, which is a major
Wei L, Gao J, Wang L, Tao Q, Tu C.
europepmc   +2 more sources

Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy

open access: yesFrontiers in Endocrinology, 2022
Canagliflozin (Cana), an anti-diabetes drug belongs to sodium-glucose cotransporter 2 inhibitor, is gaining interest because of its extra cardiovascular benefits.
Shuqin Du   +10 more
doaj   +1 more source

Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis

open access: yesFrontiers in Molecular Biosciences, 2023
The clinical therapeutics of cervical cancer is limited due to the drug resistance and metastasis of tumor. As a novel target for antitumor therapy, ferroptosis is deemed to be more susceptible for those cancer cells with resistance to apoptosis and ...
Hanqiang Shi   +9 more
doaj   +1 more source

Prognostic risk factors for diabetic retinopathy in patients with type 2 diabetes mellitus

open access: yesJournal of Ophthalmology, 2022
Purpose: To establish a relationship of diabetic retinopathy with the presence of lesions of other target organs, disease severity and the requirement for insulin therapy in patients with type 2 diabetes mellitus, and to determine the most significant ...
I. S. Alifanov, V. M. Sakovych
doaj   +1 more source

Cellular technologies in the treatment of diabetic angiopathy of the lower extremities [PDF]

open access: yesВестник Витебского государственного медицинского университета, 2022
Objectives. To study the possibility of using cellular technologies in the treatment of diabetic angiopathy of the lower extremities. Material and methods.
S.D. Fedzianin
doaj   +1 more source

The m6A-ncRNAs axis in diabetes complications: novel mechanism and therapeutic potential. [PDF]

open access: yesFront Endocrinol (Lausanne)
Diabetes, a multifaceted metabolic disorder, poses a significant global health burden with its increasing prevalence and associated complications, such as diabetic nephropathy, diabetic retinopathy, diabetic cardiomyopathy, and diabetic angiopathy ...
Yu S   +6 more
europepmc   +2 more sources

Inflammatory Activities in Type 2 Diabetes Patients With Co-morbid Angiopathies and Exploring Beneficial Interventions: A Systematic Review

open access: yesFrontiers in Public Health, 2021
Background: Diabetes is a long-term condition that can be treated and controlled but do not yet have a cure; it could be induced by inflammation and the goal of managing it is to prevent additional co-morbidities and reduce glycemic fluctuations.
Martin C. Nwadiugwu
doaj   +1 more source

ARTERIAL INFLAMMATION, BLOOD PRESSURE AND CENTRAL HEMODYNAMICS – THE ABC OF DIABETIC ANGIOPATHY

open access: yesArtery Research, 2016
Aim: In diabetes patients, we explored relationships between markers of diabetic angiopathy, diabetic complications and adverse outcome. Methods: Patients were recruited from 3 observational studies from Steno Diabetes Center, Denmark and one randomized,
Simone Theilade
doaj   +1 more source

Home - About - Disclaimer - Privacy